DE60226537D1 - Mit Morinda Citrifolia (Noni) angereichtertes Futtermittelprodukt - Google Patents

Mit Morinda Citrifolia (Noni) angereichtertes Futtermittelprodukt

Info

Publication number
DE60226537D1
DE60226537D1 DE60226537T DE60226537T DE60226537D1 DE 60226537 D1 DE60226537 D1 DE 60226537D1 DE 60226537 T DE60226537 T DE 60226537T DE 60226537 T DE60226537 T DE 60226537T DE 60226537 D1 DE60226537 D1 DE 60226537D1
Authority
DE
Germany
Prior art keywords
noni
morinda citrifolia
animal food
feed product
product enriched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60226537T
Other languages
English (en)
Inventor
John Wadsworth
Stephen P Story
Claude Jarkae Jensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tahitian Noni International Inc
Original Assignee
Tahitian Noni International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tahitian Noni International Inc filed Critical Tahitian Noni International Inc
Application granted granted Critical
Publication of DE60226537D1 publication Critical patent/DE60226537D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
DE60226537T 2001-04-17 2002-04-16 Mit Morinda Citrifolia (Noni) angereichtertes Futtermittelprodukt Expired - Lifetime DE60226537D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/836,881 US6737089B2 (en) 1999-08-27 2001-04-17 Morinda citrifolia (Noni) enhanced animal food product

Publications (1)

Publication Number Publication Date
DE60226537D1 true DE60226537D1 (de) 2008-06-26

Family

ID=25272957

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60226537T Expired - Lifetime DE60226537D1 (de) 2001-04-17 2002-04-16 Mit Morinda Citrifolia (Noni) angereichtertes Futtermittelprodukt

Country Status (5)

Country Link
US (1) US6737089B2 (de)
EP (1) EP1250849B1 (de)
JP (2) JP2003061588A (de)
AT (1) ATE394937T1 (de)
DE (1) DE60226537D1 (de)

Families Citing this family (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US6855345B2 (en) * 2001-11-02 2005-02-15 Morinda, Inc. Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions
US8790727B2 (en) * 2000-12-05 2014-07-29 Tahitian Noni International, Inc. Morinda citrifolia and iridoid based formulations
US8574642B2 (en) 2000-12-05 2013-11-05 Tahitian Noni International, Inc. Antiviral Morinda citrifolia L. based formulations and methods of administration
US8652546B2 (en) * 2007-09-06 2014-02-18 Tahitian Noni International, Inc. Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals
US20040192761A1 (en) * 2003-03-25 2004-09-30 Palu Afa Kehaati Preventative and treatment effects of morinda citrifolia as an aromatase inhibitor
US20110171333A1 (en) * 2000-12-05 2011-07-14 Bryant Wadsworth Morinda Citrifolia Based Antioxidant and Antimicrobial Formulations for Improved Color Stability and Increased Shelf Life of Various Meat Products
US20120237626A9 (en) * 2000-12-05 2012-09-20 Palu Afa Kehaati Profiles of lipid proteins and inhibiting HMG-CoA reductase
US20110217394A1 (en) * 2000-12-05 2011-09-08 Brett Justin West Iridoid Based Formulations
US7244463B2 (en) * 2005-10-18 2007-07-17 Tahitian Noni International, Inc. Garcinia mangostana L. enhanced animal food product
EP1389124A4 (de) * 2001-04-17 2004-12-15 Morinda Inc Palliative wirkungen von öl und saft von morinda citrifolia
GB0113348D0 (en) * 2001-06-01 2001-07-25 Mars Uk Ltd Skin diet
WO2002098433A1 (fr) * 2001-06-01 2002-12-12 Ajinomoto Co., Inc. Medicaments pour les maladies intestinales
US7666459B2 (en) * 2001-09-12 2010-02-23 The Procter & Gamble Company Pet food compositions
IL160906A0 (en) * 2001-09-19 2004-08-31 Conagra Grocery Prod Co System and method for producing concentrated food products with fractionation concentration
US7070813B2 (en) * 2001-11-02 2006-07-04 Morinda, Inc. Preventative and treatment effects of morinda citrifolia as a colon cancer cell growth inhibitor
US20030134002A1 (en) * 2001-11-02 2003-07-17 Jensen Claude Jarakae Method for treating visual impairment through the prophylactic administration of a Morinda citrifolia-based naturaceutical
US20110160057A1 (en) * 2001-11-14 2011-06-30 Bryant Wadsworth Morinda Citrifolia Based Antimicrobial Formulations
US7442395B2 (en) * 2002-11-14 2008-10-28 Tahitian Noni International, Inc. Formulation for treating candidiasis using Morinda citrifolia
US20040037942A1 (en) * 2002-08-20 2004-02-26 Shah Naina Kiran Composition
WO2004019699A1 (en) * 2002-08-30 2004-03-11 Campina B.V. Foaming ingredient and products containing the ingredient
US8034372B2 (en) * 2003-03-05 2011-10-11 Nestec, Ltd. Dietary supplement for athletic pets
US20060269630A1 (en) * 2003-04-16 2006-11-30 Palu Afa K Morinda citrifolia as a 5-Lipoxygenase inhibitor
WO2004096252A1 (en) * 2003-04-25 2004-11-11 Primavera Biosciences, Inc. Compositions and methods for weight loss
JP4073826B2 (ja) * 2003-06-04 2008-04-09 タヒチアン ノニ インターナショナル インコーポレーテッド ヤエヤマアオキの抽出物を含む農業用活力剤
US20060240037A1 (en) * 2003-06-04 2006-10-26 Edward Fey Methods and compositions for the treatment and prevention of degenerative joint disorders
US20050037101A1 (en) * 2003-08-12 2005-02-17 Mian-Ying Wang Preventative effects of morinda citrifolia on mammary breast cancer
US20070259060A1 (en) * 2003-08-12 2007-11-08 Mian-Ying Wang Formulations and Methods for Treating Breast Cancer with Morinda Citrifolia and Methylsulfonymethane
US20050084551A1 (en) * 2003-09-26 2005-04-21 Jensen Claude J. Morinda citrifolia-based oral care compositions and methods
US7754677B2 (en) * 2003-12-05 2010-07-13 Hill's Pet Nutrition, Inc. Composition and method for reducing diarrhea in a mammal
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20050158412A1 (en) * 2004-01-05 2005-07-21 Chen Su Type II diabetes
US8377904B2 (en) * 2004-02-09 2013-02-19 Hill's Pet Nutrition, Inc. Composition and method for use in cartilage affecting conditions
US20070031534A1 (en) * 2004-02-27 2007-02-08 Hajime Tsujimoto Pet food for reducing food allergy reactions
US20050202108A1 (en) * 2004-03-10 2005-09-15 Palu Afa K. Methods and compositions for inhibiting angiotensin converting and chymase enzymes
US20050260291A1 (en) * 2004-03-10 2005-11-24 Palu Afa K Methods and compositions for reactivating acetylcholinesterase
US8685438B2 (en) * 2004-03-17 2014-04-01 The Iams Company Compositions, kits, and methods utilizing an added boron source
US20050238654A1 (en) * 2004-04-26 2005-10-27 Yoshinori Takeda Compositions and methods for weight loss
US20090252834A1 (en) * 2004-05-10 2009-10-08 Michael Griffin Hayek Compositions comprising glucose anti-metabolites
US20050249837A1 (en) * 2004-05-10 2005-11-10 The Procter & Gamble Company Processes for preparing plant matter extracts and pet food compositions
EP1597978A1 (de) 2004-05-17 2005-11-23 Nutricia N.V. Synergie von GOS und polyfruktose
US7112343B1 (en) * 2004-05-24 2006-09-26 Robbie Shoemake Immune system reconstructor composition
US20050266051A1 (en) * 2004-05-27 2005-12-01 The Procter & Gamble Company Pet food compositions and methods
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1723951A1 (de) * 2005-04-21 2006-11-22 N.V. Nutricia Nahrungsergänzungspräparat mit Oligosacchariden für eine Kategorie von HIV Patienten
EP1721611A1 (de) * 2005-04-21 2006-11-15 N.V. Nutricia Nahrungsergänzungspräparat mit Oligosacchariden für eine Kategorie von HIV Patienten
CA2570208A1 (en) * 2004-06-22 2005-12-29 N.V. Nutricia Improvement of barrier integrity in hiv patients
WO2006047416A2 (en) * 2004-10-25 2006-05-04 Wadsworth John W Garcinia mangostana l. enhanced animal food product
US20060204601A1 (en) * 2005-03-09 2006-09-14 Palu Afa K Formulations and methods for preventing and treating substance abuse and addiction
DE602006015042D1 (de) * 2005-04-21 2010-08-05 Nutricia Nv Nahrungsergänzungsmittel für hiv-patienten
US7536364B2 (en) * 2005-04-28 2009-05-19 General Electric Company Method and system for performing model-based multi-objective asset optimization and decision-making
US20060247798A1 (en) * 2005-04-28 2006-11-02 Subbu Rajesh V Method and system for performing multi-objective predictive modeling, monitoring, and update for an asset
JP5296531B2 (ja) 2005-05-05 2013-09-25 センシエント フレイバーズ エルエルシー βグルカン及びマンナンの製造
US7700142B2 (en) * 2005-05-16 2010-04-20 Diane Wright Hoffpauer Fortified cereal bran to promote digestive health
US20060280818A1 (en) * 2005-05-26 2006-12-14 Palu Afa K Nicotinic acetylcholine receptor antagonist
US20070122507A1 (en) * 2005-05-26 2007-05-31 Palu Afa K Histone deacetylase and tumor necrosis factor converting enzyme inhibition
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
EP2270131A1 (de) 2005-05-31 2011-01-05 The Iams Company Probiotische Katzen-Laktobazillen
DE102005031364A1 (de) * 2005-06-30 2007-01-11 Ernst-Moritz-Arndt-Universität Greifswald Nahrungsergänzungsmittel mit verbesserten antioxidativen Eigenschaften
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
US7955418B2 (en) 2005-09-12 2011-06-07 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (DMSO) or related compounds or odors associated with same
WO2007033180A1 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
EP2324838A1 (de) 2005-09-12 2011-05-25 Abela Pharmaceuticals, Inc. Zusammensetzungen mit Dimethyl-Sulfoxid
US20070071809A1 (en) * 2005-09-26 2007-03-29 Vad Vijay B Ginger containing compositions to control pain
US20070154579A1 (en) * 2005-11-29 2007-07-05 Palu Afa K Morinda Citrifolia Based Formulation And Methods For Weight Management
US20070166417A1 (en) * 2005-11-29 2007-07-19 Palu Afa K Formulation and Methods for Use of Morinda Citrifolia Seed Oil
US20070184137A1 (en) * 2005-11-29 2007-08-09 Palu Afa K Morinda Citrifolia L. Based Formulations for Inhibiting Matrix Metalloproteinase Enzymes
JP2007169247A (ja) * 2005-12-26 2007-07-05 Seikatsu Bunkasha:Kk ショウガ含有経口組成物
US20070298142A1 (en) * 2006-01-20 2007-12-27 Godbee Richard G Morinda Citrifolia Enhanced Products For Administration To Animals
WO2007084983A2 (en) * 2006-01-20 2007-07-26 Tahitian Noni International, Inc. Morinda citrifolia enhanced products for administration to animal
PL2010005T3 (pl) 2006-03-21 2010-04-30 Taminco Bvba Traktowanie drobiu w celu zmniejszenia współczynnika wykorzystania paszy lub zmniejszenia zapadalności na wodobrzusze
US20070281903A1 (en) * 2006-05-04 2007-12-06 Palu Afa K Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX
US8025910B2 (en) 2006-05-12 2011-09-27 Tahitian Noni International, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
US8535741B2 (en) 2006-05-12 2013-09-17 Morinda, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
ES2751020T3 (es) * 2006-06-08 2020-03-30 Iams Europe B V Composición para mejorar la salud ocular
FR2903860B1 (fr) * 2006-07-21 2010-12-31 Royal Canin Sa Aliment sec pour reduire l'appetit des chiens
MX2009008165A (es) * 2007-02-01 2009-08-12 Iams Company Metodo para disminuir la inflamacion y el esfuerzo oxidante en mamiferos.
PL2124966T3 (pl) * 2007-02-01 2016-01-29 Iams Europe B V Sposób zmniejszania reakcji zapalnej i stresu u ssaków za pomocą antymetabolitów glukozy, awokado lub ekstraktów awokado
US20080206368A1 (en) * 2007-02-26 2008-08-28 Mian-Ying Wang Administration of Morinda Citrifolia L. Based Formulations to Increase Birth Rates
US9420807B2 (en) 2007-04-02 2016-08-23 Purina Animal Nutrition Llc Method of feeding young monogastric mammals and composition fed to young monogastric mammals
US20080317890A1 (en) * 2007-06-21 2008-12-25 Claude Jarakae Jensen Method for treating visual impairment through the prophylactic administration of a morinda citrifolia-based naturaceutical
WO2009033502A1 (en) * 2007-09-12 2009-03-19 Taminco Treatment of pigs for reducing the feed conversion ratio or increasing the growth rate
WO2009096772A1 (en) * 2008-02-01 2009-08-06 N.V. Nutricia Composition for stimulating natural killer cell activity
US20090196944A1 (en) * 2008-02-01 2009-08-06 Brad Rawson Methods of Manufacture of Morinda Citrifolia Based Compositions for Treatment of Anti-Inflammatory Diseases through Inhibition of Cox-1, Cox-2, Interleukin -1beta, Interleukin-6, TNF-alpha, HLE, and iNOS
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
JP5436895B2 (ja) * 2009-03-13 2014-03-05 サントリーホールディングス株式会社 水抽出コンドロイチンおよびミルク香料を含む経口製剤
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP2489653B1 (de) * 2009-10-16 2017-11-29 Kaneka Corporation Verfahren zur produktion von reduziertem coenzym q10 und mittel umfassend selbiges
US9855212B2 (en) 2009-10-30 2018-01-02 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases
US20110206786A1 (en) * 2010-02-23 2011-08-25 Brett Justin West Acai and Iridoid Based Formulations
WO2012050979A1 (en) * 2010-09-29 2012-04-19 Jiantao Gao Novel feed additive
ES2386474B1 (es) * 2011-01-21 2013-07-09 Norel, Sa Aditivos para alimentación animal.
US8975310B2 (en) 2011-07-20 2015-03-10 Brigham Young University Hydrophobic ceragenin compounds and devices incorporating same
CN102524539B (zh) * 2012-01-18 2013-04-03 丁国成 一种动物保健剂组合物及其制备工艺
EP3225113B1 (de) 2012-05-02 2020-09-02 Brigham Young University Verfahren zur herstellung von cerageninmaterialien in partikelform
US9387215B2 (en) * 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
CN103404701B (zh) * 2013-08-26 2015-08-05 成都乾坤动物药业有限公司 一种改善禽畜肌肉口感的兽用组合物及其制备方法和用途
CN103704492A (zh) * 2013-09-06 2014-04-09 广德优维坊宠物食品有限公司 一种宠物强效亮毛增色组合
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
HU230683B1 (hu) * 2014-07-03 2017-08-28 Emil Szanto Korpát tartalmazó étrend kiegészítõ és roboráló készítmény
CN104171436B (zh) * 2014-09-11 2016-04-06 东北农业大学 一种肉用鹌鹑抗冷应激且同时改善肉质的饲料添加剂及饲料
KR101675456B1 (ko) * 2014-11-21 2016-11-15 (주) 에이티바이오 면역력 향상용 사료 및 면역력 향상용 사료의 제조방법
KR101652075B1 (ko) * 2015-04-28 2016-08-29 강석상 적색 셰일을 이용한 가축사료 조성물
CN104872395B (zh) * 2015-06-05 2018-06-19 西双版纳华坤生物科技有限责任公司 一种富含ω-3脂肪酸和共轭亚油酸的牛奶及其生产方法
ES2952744T3 (es) * 2016-12-15 2023-11-03 Nestle Sa Composiciones y procedimientos que modulan los glóbulos blancos o los neutrófilos en un animal de compañía
CN106852936A (zh) * 2016-12-21 2017-06-16 泰州市贝诺生物科技有限公司 宠物壮骨关节膏及其制备方法
US10287366B2 (en) 2017-02-15 2019-05-14 Cp Kelco Aps Methods of producing activated pectin-containing biomass compositions
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
KR102609440B1 (ko) * 2021-05-28 2023-12-05 로얄캐니펠 주식회사 동애등에, 아몬드피, 난각을 포함하는 가축용 배합사료

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5431927A (en) 1992-06-16 1995-07-11 Colgate-Palmolive Company Pet food product having oral care properties
US5288491A (en) * 1992-09-24 1994-02-22 Herbert Moniz Noni (Morinda Citrifolia) as a pharmaceutical product
US5616569A (en) 1994-03-28 1997-04-01 The Iams Company Pet food product containing fermentable fibers and process for treating gastrointestinal disorders
US5962043A (en) 1996-02-29 1999-10-05 Seal Rock Technologies Incorporated Weight reduction method for dogs and other pets
US6133323A (en) 1997-04-09 2000-10-17 The Iams Company Process for enhancing immune response in animals using β-carotene as a dietary supplement
US5851573A (en) 1997-04-29 1998-12-22 The Iams Company Pet food composition for large breed puppies and method for promoting proper skeletal growth
US5770217A (en) * 1997-07-02 1998-06-23 Atlatl, Inc. Dietary supplement for hematological, immune and appetite enhancement
US6405948B1 (en) * 1997-07-18 2002-06-18 Pulsewave Llc Liberating intracellular matter from biological material
US6039952A (en) 1997-10-22 2000-03-21 The Iams Company Composition and method for improving clinical signs in animals with renal disease
US5976549A (en) * 1998-07-17 1999-11-02 Lewandowski; Joan Method to reduce bad breath in a pet by administering raw garlic
FR2783137A1 (fr) * 1998-09-10 2000-03-17 Royal Tahiti Noni Composition a base d'extraits de morinda citrifolia
US6156355A (en) 1998-11-02 2000-12-05 Star-Kist Foods, Inc. Breed-specific canine food formulations
US6299925B1 (en) * 1999-06-29 2001-10-09 Xel Herbaceuticals, Inc. Effervescent green tea extract formulation
US6254913B1 (en) * 1999-08-27 2001-07-03 Morinda, Inc. Morinda citrifolia dietary fiber and method
US6214351B1 (en) * 1999-08-27 2001-04-10 Morinda, Inc. Morinda citrifolia oil
US6436449B2 (en) * 2000-03-02 2002-08-20 Bo Gidlund Use of a composition
SE516468C2 (sv) * 2000-03-02 2002-01-15 Bo Gidlund Användning av ett extrakt från Morinda citrifolia L. för framställning av läkemedel för behandling av tinnitus.

Also Published As

Publication number Publication date
JP2003061588A (ja) 2003-03-04
US6737089B2 (en) 2004-05-18
EP1250849A1 (de) 2002-10-23
US20020182276A1 (en) 2002-12-05
ATE394937T1 (de) 2008-05-15
JP2006280382A (ja) 2006-10-19
EP1250849B1 (de) 2008-05-14

Similar Documents

Publication Publication Date Title
DE60226537D1 (de) Mit Morinda Citrifolia (Noni) angereichtertes Futtermittelprodukt
SE0203713D0 (sv) Novel compounds
ID28024A (id) Metode bagi produksi 1,3-propanadiol oleh organisme-organisme rekombinan yang mengandung ge-gen untuk pengakutan vitamin b12
SI1536827T1 (sl) Uporaba protein-kinaze n beta
CY1109104T1 (el) 1,2,3,4 τετρα-υποκατεστημενη ινδολη για την αντιμετωπιση ασθενειων του αναπνευστικου
CR7742A (es) Formulaciones para uso veterinario que contienen productos de origen no animal
BRPI0414598A (pt) indóis substituìdos
CY1110541T1 (el) Φαρμακευτικα σκευασματα με βελτιωμενες φαρμακευτικες ιδιοτητες που περιεχουν βελτιωτικα γευσης
DE69525545D1 (de) Wirkstoff zur erhöhung der produktion und der zucht von tieren in der geflügelindustrie
ATE408601T1 (de) Fredericamycin-derivate
ATE433671T1 (de) Verfahren und zusammensetzung zur vergroesserung der milchproduktion
ATE406884T1 (de) Zusammensetzungen mit pantothensäure oder derivaten davon und ihre verwendung zur stimulierung des appetits
ATE347555T1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
ATE372776T1 (de) Arzneimittel enthaltend deuterium zur behandlung der zuckerkrankheit
PA8448601A1 (es) Producto alimenticio congelado
WO2006047416A3 (en) Garcinia mangostana l. enhanced animal food product
CR10319A (es) Formulaciones precisas derivadas de acido nodulisporico para combatir parasitos
EA200401289A1 (ru) Новые противоинфекционные соединения, способы их получения и фармацевтические композиции, содержащие эти соединения
ITMI20022704A1 (it) Procedimento per la produzione di mesitilene e durene.
ITMO20030254A1 (it) Impianto per la concentrazione del succo di pomodoro.
TW200633645A (en) Increase in the protein proportion of animal organisms
MXPA04000272A (es) Derivados de 4-aminociclohexanol sustituidos.
FI991533A (fi) Menetelmä orgaanisten aineiden käsittelemiseksi
ATE286879T1 (de) Synthesezwischenprodukte zur herstellung von vitamin d-derivaten
UA33231A (uk) Спосіб добору великої рогатої худоби з прогнозованим ефектом селекції по молочності і м'ясності

Legal Events

Date Code Title Description
8364 No opposition during term of opposition